Harbin Medical University
Clinical trials sponsored by Harbin Medical University, explained in plain language.
-
New pill combo could slow stomach cancer progression
Disease control Not yet recruitingThis study tests whether taking two oral drugs—paclitaxel solution and fruquintinib—can help people with advanced stomach or gastroesophageal junction cancer live longer without their disease getting worse. It is for patients whose cancer did not respond to or caused side effects…
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Heart attack breakthrough? Drug-Only approach may rival stents in mild cases
Disease control Not yet recruitingThis study looks at whether standard medication alone is as good as medication plus a stent for people having a heart attack with only mild blockages. About 2,000 patients will be randomly assigned to get either just medication or medication plus a stent. The goal is to see if th…
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Heart scan strategy aims to slash cardiac events in rural china
Disease control Not yet recruitingThis study tests whether using a special heart scan (coronary CTA) to guide intensive treatment can reduce major heart problems like heart attacks and strokes compared to standard care. About 15,000 high-risk adults aged 40-75 in rural China will take part. The main goal is to se…
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New app aims to ease stress for parents of kids with autism
Symptom relief Not yet recruitingThis study tests a mobile app called "Heart Voice: Starry Journey" designed to help parents and caregivers of children with autism feel more flexible and less stressed. About 52 caregivers will either use the app for 6 weeks or continue their usual routine. The goal is to see if …
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC